AAAAAA

   
Results: 1-8 |
Results: 8
Re: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselectedFinnish breast cancer patients - Response
Authors: Vahteristo, P Syrjakoski, K Eerola, H Kainu, T Holli, K Blomqvist, C Kallioniemi, OP Nevanlinna, H
Citation: P. Vahteristo et al., Re: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselectedFinnish breast cancer patients - Response, J NAT CANC, 93(2), 2001, pp. 153-154
Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families
Authors: Barkardottir, RB Sarantaus, L Arason, A Vehmanen, P Bendahl, PO Kainu, T Syrjakoski, K Krahe, R Huusko, P Pyrhonen, S Holli, K Kallioniemi, OP Egilsson, V Kere, J Nevanlinna, H
Citation: Rb. Barkardottir et al., Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families, EUR J HUM G, 9(10), 2001, pp. 773-779
A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland
Authors: Mononen, N Ikonen, T Syrjakoski, K Matikainen, M Schleutker, J Tammela, TLJ Koivisto, PA Kallioniemi, OP
Citation: N. Mononen et al., A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland, BR J CANC, 84(10), 2001, pp. 1344-1347
Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites
Authors: Rapakko, K Allinen, M Syrjakoski, K Vahteristo, P Huusko, P Vahakangas, K Eerola, H Kainu, T Kallioniemi, OP Nevanlinna, H Winqvist, R
Citation: K. Rapakko et al., Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites, BR J CANC, 84(1), 2001, pp. 116-119
Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients
Authors: Syrjakoski, K Vahteristo, P Eerola, H Tamminen, A Kivinummi, K Sarantaus, L Holli, K Blomqvist, C Kallioniemi, OP Kainu, T Nevanlinna, H
Citation: K. Syrjakoski et al., Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients, J NAT CANC, 92(18), 2000, pp. 1529-1531
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland
Authors: Sarantaus, L Huusko, P Eerola, H Launonen, V Vehmanen, P Rapakko, K Gillanders, E Syrjakoski, K Kainu, T Vahteristo, P Krahe, R Paakkonen, K Hartikainen, J Blomqvist, C Lopponen, T Holli, K Ryynanen, M Butzow, R Borg, A Arver, BW Holmberg, E Mannermaa, A Kere, J Kallioniemi, OP Winqvist, R Nevanlinna, H
Citation: L. Sarantaus et al., Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland, EUR J HUM G, 8(10), 2000, pp. 757-763
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus
Authors: Kainu, T Juo, SHH Desper, R Schaffer, AA Gillanders, E Rozenblum, E Freas-Lutz, D Weaver, D Stephan, D Bailey-Wilson, J Kallioniemi, OP Tirkkonen, M Syrjakoski, K Kuukasjarvi, T Koivisto, P Karhu, R Holli, K Arason, A Johannesdottir, G Bergthorsson, JT Johannsdottir, H Egilsson, V Barkardottir, RB Johannsson, O Haraldsson, K Sandberg, T Holmberg, E Gronberg, H Olsson, H Borg, A Vehmanen, P Eerola, H Heikkila, P Pyrhonen, S Nevanlinna, H
Citation: T. Kainu et al., Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus, P NAS US, 97(17), 2000, pp. 9603-9608
Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene
Authors: Mononen, N Syrjakoski, K Matikainen, M Tammela, TLJ Schleutker, J Kallioniemi, OP Trapman, J Koivisto, PA
Citation: N. Mononen et al., Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene, CANCER RES, 60(22), 2000, pp. 6479-6481
Risultati: 1-8 |